Global Biopharmaceutical Contract Manufacturing (BCMO) Market, 2017-2022 - Preferred Vendor Relationships, CMO M&A, Big Pharma in CM, Vertical Integration and Other Important Trends

News provided by

Dec 05, 2017, 10:15 ET

DUBLIN, Dec. 5, 2017 /PRNewswire/ --

The "Biopharmaceutical Contract Manufacturing (BCMO) Market - by Type of Service, by Organization and by Region" report has been added to Research and Markets' offering.

How Large is the Biopharmaceutical Contract Manufacturing Opportunity? Will the Drive for New Biopharma Last? Who are the Key Players in this Industry?

These are among the questions answered by report on biomanufacturing organizations, labelled BCMOs. The market for biopharmaceutical manufacturing is driven by many factors - an aging population, demand for more effective solutions to disease, and the expiration of blockbusters. Over the past several years, an unprecedented number of blockbuster drugs have lost patent protection, and this trend is expected to continue through the foreseeable future. Because generic medicines are priced at a discount of up to 90% of the cost of the original drug, yet are considered therapeutically identical, their growing usage represents a particularly threat to blockbuster drugs. Yet pharmaceutical companies cannot always produce their needed pipeline in-house. This has created an ideal market environment for biopharmaceutical contracting.

This report, Biopharmaceutical Contract Manufacturing Market ( BCMOs) Markets by Type of Service, CMO and Region, contains the following market information:

BCMO Market 2012-2022
Top Company Revenues
BCMO Country Markets (U.S., Western Europe, Eastern Europe, China, India, Other Asia, Latin America, Rest of World)
BCMO Market by Segment (Clinical Manufacturing, Commercial Manufacturing)
Company Profiles
Preferred Vendor Relationships, CMO M&A, Big Pharma in CM, Vertical Integration and Other Important Trends

This report includes extensive coverage of the biotechnology segment of the global drug development and manufacturing industry. Sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for the historic 2012 to 2017 period and forecasts are provided through 2022. Historical information for this report was gathered from a wide variety of published sources including company reports, filings, websites and presentations; government documents; legal filings; trade journals; newspapers and business press; analysts' reports and other sources. Interviews with company representatives were conducted to capture the perspectives from industry participants' point of view and assess trends, and form the basis of the forecasting and competitive analysis.

Best efforts were made to determine BCMO fees by region in the many instances where these are not specifically reported by each company. Contract manufacturing fees were allocated to the country/region of production, not to the region of export; therefore, companies with production facilities in a single country, such as China, were deemed to be regional Chinese players even if they have extensive export operations to many other countries. These determinations were made on the basis of currently available information. Where reliable information was not attainable, no estimate was attempted.

Key Topics Covered:

1: Executive Summary

The Biopharmaceutical Contract Manufacturing (Bcmo) Industry
Scope And Methodology
The Bcmo Services Market

2: Overview

Introduction
Rising Pressures On Pharmaceutical And Biotech Drug Makers
Blockbuster Patent Expirations and Genericization
Ever-Rising R&D Costs
Delays in Clinical Study Recruitment
Heightened Regulatory Scrutiny
Decreasing Drug Approvals
Drug Pricing Pressures
Excess Manufacturing Capacity
TECHNOLOGY SHIFTS
Biotechnology
Biosimilars

3: The Contract Manufacturing Industry

Contract Manufacturing Organizations
The Role of BCMOs
Services Offered by BCMOs
The Rise of CDMOs
Swot Analysis
Strengths
Opportunities
Weaknesses
Threats

4: The BCMO Market In The U.S. And Western Europe

Introduction
The U.S. Bcmo Market
Overview
Market Forecasts
Market Drivers
Market Restraints
Key Players and U.S. Share
The Western European Bcmo Market
Overview
Market Forecasts
Market Drivers
Market Restraints
Key Players and Western European Share

5: The BCMO Market In The Emerging Regions

Introduction
The Eastern European Bcmo Market
Overview
Infrastructure and Local Regulations
Intellectual Property Issues
Market Forecasts
Market Drivers
Market Restraints
Key Players and Eastern European Share
The Chinese Bcmo Market
Overview
Infrastructure and Local Regulations
Intellectual Property Issues
Market Forecasts
Market Drivers
Market Restraints
Key Players and Chinese Share
The Indian Bcmo Market
Overview
Infrastructure and Local Regulations
Intellectual Property Issues
Market Forecasts
Market Drivers
Market Restraints
Key Players and Indian Share
The Asian Bcmo Market, Excluding China And India
Overview
Infrastructure and Local Regulations
Intellectual Property Issues
Market Forecasts
Market Drivers
Market Restraints
Key Players and Other Asian Share
The Latin American Bcmo Market
Overview
Infrastructure and Local Regulations
Intellectual Property Issues
Market Forecasts
Market Drivers
Market Restraints
Key Players and Latin American Share
The Rest Of World (Row) Market
Overview
Market Forecasts
Market Drivers
Market Restraints
Key Players and ROW Share

6: Total Global Bcmo Market

Overview
Market Forecasts
Key Players And Global Market Share
Future Market Trends
The Future Of Pharma And Biopharma Manufacturing
The Future Of Contract Manufacturing

7: Issues And Trends

Expansion Of Overseas Bcmos
Preferred Vendor Relationships
Contract Organization Mergers And Acquisitions
Entrance Of Big Pharma Into Contract Manufacturing
Vertical And Supply Chain Integration
Wuxiapptec
Other Supply Chain Integration Opportunities
Emergence Of Speciality Bcmo Players
CMC Biologics
Fresenius Kabi
Risk Sharing Programs
Reduced Gdufa Fees

8: Pharmaceutical & Biotech Company Profiles

3P Biopharmaceuticals
Abbvie
Aenova
Amri
Asahi Glass Co.
Aurobindo
Avara Pharmaceutical Services
Baxter Biopharma Solutions
Boehringer Ingelheim Bioxcellence
Catalent
Celonic AG
Cytovance Biologics
DM Bio
Dr. Reddy'S Laboratories
Fareva
Fresenius Kabi Product Partnering
Fujifilm Diosynth Biotechnologies
Glaxosmithkline Biopharmaceuticals
Grifols
Idifarma
Jubilant Life Sciences
Juniper Pharmaceutical Services
Kemwell Biopharma
LFB SA
Lonza
Luinabio
Menarini Biotech
Novasep
Particle Sciences
Patheon/Thermo Fisher Scientific
Pfizer Centreone
Piramal
Recipharm
Rentschler Biotechnologie Gmbh
Rovi Contract Manufacturing
Samsung Biologics
Siegfried AG
Sl Pharma Labs
Strides Shashun Ltd.
Symbiosis Pharmaceutical Services
Syngene International
TCG Lifesciences
Teuto
Therapure Biopharma
Tianjin Pharmaceutical
UPM Pharmaceuticals
Vetter Pharma International Gmbh
Woodfield Pharmaceutical
Wuxi Apptec

For more information about this report visit https://www.researchandmarkets.com/research/gc4ztf/biopharmaceutical

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets